Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children
| Status: | Completed | 
|---|---|
| Conditions: | Cosmetic, Dermatology, Dermatology, Hair Loss | 
| Therapuetic Areas: | Dermatology / Plastic Surgery | 
| Healthy: | No | 
| Age Range: | Any | 
| Updated: | 11/18/2012 | 
| Start Date: | June 2010 | 
| End Date: | November 2012 | 
| Contact: | Allergan Inc. | 
| Email: | clinicaltrials@allergan.com | 
This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily
application to the upper eyelid margins compared with vehicle in treating eyelash loss or
hypotrichosis (inadequate or not enough eyelashes) in children
Inclusion Criteria:
- Children who have inadequate eyelashes or have lost their eyelashes as a result of
chemotherapy treatment, who completed their chemotherapy (intensive treatment) at
least 4 weeks before starting the study, are considered to be at low risk for relapse
of their cancer, and are well enough to complete the study
- Children who have minimal to moderate inadequate eyelashes due to alopecia areata
- Adolescents between the ages of 15-17 years who have minimal to marked inadequate
eyelashes
Exclusion Criteria:
- Any eye disease or abnormality, eye surgery, permanent eyeliner, eyelash implants.
- Semi-permanent eyelash tint, dye or eyelash extension application within 3 months
- Use of over the counter eyelash growth products within 6 months.
- Use of prescription eyelash growth products (eg, Latisse®)
- Any eye condition that would prevent required ophthalmology exams
We found this trial at
    1
    site
	Click here to add this to my saved trials